{"id":209668,"name":"AVALO THERAPEUTICS","slug":"avalo-therapeutics","state":"MD","country":"United States of America","description":"Biopharmaceutical company","totalSpending":260000,"filings":14,"yearlySpending":[{"year":2021,"income":80000},{"year":2022,"income":150000},{"year":2023,"income":30000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"PHA","display":"Pharmacy"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["BURRELL INTERNATIONAL GROUP LLC"],"lobbyists":["DEBORAH BURRELL"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Appropriations and funding for client projects, products, and services; Drug Pricing, Rare Disease Cures, cell and gene therapy.","Appropriations and funding for client projects, products, and services; Drug Pricing, Rare Disease Cures, cell and gene therapy.","Appropriations and funding for client projects, products, and services; Drug Pricing, Rare Disease Cures, cell and gene therapy.","Appropriations and funding for client projects, products, and services; Drug Pricing, Rare Disease Cures, cell and gene therapy.","Medical Countermeasures Development of Therapeutics for COVID-19 and Rare Disease"]}